On July 28, 2023, Christopher Loose, Ph.D., notified Frequency Therapeutics, Inc. that he would be resigning from his position as Chief Scientific Officer of the Company, effective July 28, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.9 USD | -2.70% | -12.61% | +6.15% |
Apr. 24 | Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing | MT |
Apr. 24 | Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.15% | 485M | |
+23.21% | 46.71B | |
+48.83% | 41.8B | |
-1.15% | 41.52B | |
-3.42% | 29.55B | |
+10.53% | 25.78B | |
-21.17% | 19.26B | |
+0.06% | 12.14B | |
-0.07% | 12.08B | |
+26.25% | 11.98B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Frequency Therapeutics, Inc. Announces the Resignation of Christopher Loose as Chief Scientific Officer